Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ASP Isotopes (ASPI) EBIT (2022 - 2025)

ASP Isotopes has reported EBIT over the past 4 years, most recently at -$25.0 million for Q4 2025.

  • On a quarterly basis, EBIT fell 227.14% to -$25.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$59.9 million, a 127.32% decrease, with the full-year FY2025 number at -$59.9 million, down 127.32% from a year prior.
  • EBIT reached -$25.0 million in Q4 2025 per ASPI's latest filing, down from -$15.0 million in the prior quarter.
  • The five-year high for EBIT was -$827959.0 in Q2 2022, with the low at -$25.0 million in Q4 2025.
  • The 4-year median for EBIT is -$4.9 million (2023), against an average of -$6.7 million.
  • Peak YoY movement for EBIT: plummeted 425.09% in 2023, then crashed 36.76% in 2025.
  • Tracing ASPI's EBIT over 4 years: stood at -$1.5 million in 2022, then tumbled by 175.73% to -$4.0 million in 2023, then tumbled by 90.1% to -$7.6 million in 2024, then crashed by 227.14% to -$25.0 million in 2025.
  • According to Business Quant data, EBIT over the past three periods came in at -$25.0 million, -$15.0 million, and -$12.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.